Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease

• Ngā kaituhi matua: Dobromiła Osuch (Author), Piotr Zatyka (Author), Adam Słomczyński (Author), Agata Pawłowska (Author), Michal Rabenda (Author), Piotr Janik (Author), Dominika Opala (Author)
• Hōputu: Pukapuka
• I whakaputaina: Nicolaus Copernicus University in Toruń, 2024-08-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Introduction: Inflammatory bowel disease (IBD) is a chronic condition that involves long-term treatment and chronic idiopathic inflammation within the gastrointestinal tract. The predominant forms of IBD are: Crohn's disease and ulcerative colitis. These diseases cause significant physical as w...